FRIDAY, Nov. 1, 2024 -- Vasomotor symptoms (VMS) during the menopause transition (MT) are associated with an increased risk for type 2 diabetes (T2D),...
Vous n'êtes pas connecté
TUESDAY, Aug. 27, 2024 -- For menopausal vasomotor symptoms (VMS), elinzanetant is efficacious and well-tolerated, according to a study published online Aug. 22 in the Journal of the American Medical Association. JoAnn V. Pinkerton, M.D., from the...
FRIDAY, Nov. 1, 2024 -- Vasomotor symptoms (VMS) during the menopause transition (MT) are associated with an increased risk for type 2 diabetes (T2D),...
FRIDAY, Nov. 1, 2024 -- Vasomotor symptoms (VMS) during the menopause transition (MT) are associated with an increased risk for type 2 diabetes (T2D),...
TUESDAY, Oct. 29, 2024 -- Genome sequencing of newborns is both feasible and acceptable for parents of a diverse newborn population, according to a...
TUESDAY, Nov. 5, 2024 -- There is a bidirectional association for rheumatoid arthritis (RA) and interstitial lung disease (ILD), according to a study...
TUESDAY, Nov. 5, 2024 -- Obstructive sleep apnea (OSA) contributes to dementia risk in older adults, particularly women, according to a study...
THURSDAY, Oct. 24, 2024 -- Nicotine delivered by either chronic electronic cigarettes or standard cigarettes disrupts normal heart function, according...
TUESDAY, Oct. 29, 2024 -- Many Medicare beneficiaries are at risk for financial hardship from the costs of a single hospital stay, according to a...
MONDAY, Nov. 4, 2024 -- More than one-third of patients have emergency department use within 90 days before a confirmed cancer diagnosis, according to...
FRIDAY, Nov. 1, 2024 -- Drug-related reports of supply chain issues are less likely to result in drug shortages in Canada than in the United States,...
FRIDAY, Nov. 1, 2024 -- Drug-related reports of supply chain issues are less likely to result in drug shortages in Canada than in the United States,...